Ferramentas de rastreamento
Os pacientes devem ser rastreados para transtornos decorrentes do uso de bebidas alcoólicas usando uma ferramenta de avaliação formal, como AUDIT-C Alcohol Use Disorders Identification Test - Consumption), FAST (Fast Alcohol Screening Test) ou CAGE.[9]Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90.
http://www.ncbi.nlm.nih.gov/pubmed/29301420?tool=bestpractice.com
[43]Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-33.
https://www.doi.org/10.1002/hep.30866
http://www.ncbi.nlm.nih.gov/pubmed/31314133?tool=bestpractice.com
Alcohol use disorders identification test consumption (AUDIT C)
Opens in new window
Fast Alcohol Screening Test (FAST)
Opens in new window
CAGE questionnaire
Opens in new window O AUDIT (teste de identificação de transtornos devido ao uso de álcool) completo também pode ser usado, mas demora mais que outras ferramentas de rastreamento para ser realizado e, portanto, pode não ser adequado em ambientes hospitalares de cuidados agudos.[9]Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90.
http://www.ncbi.nlm.nih.gov/pubmed/29301420?tool=bestpractice.com
[43]Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-33.
https://www.doi.org/10.1002/hep.30866
http://www.ncbi.nlm.nih.gov/pubmed/31314133?tool=bestpractice.com
[57]Victor M, Adams RD. The effect of alcohol on the nervous system. Res Publ Assoc Res Nerv Ment Dis. 1953;32:526-73.
http://www.ncbi.nlm.nih.gov/pubmed/13134661?tool=bestpractice.com
O National Institute on Alcohol Abuse and Alcoholism (NIAAA) recomenda um rastreamento inicial de uma pergunta, para identificar potenciais transtornos decorrentes do uso de bebidas alcoólicas: "Quantas vezes, no último ano, você tomou X ou mais doses em um dia?", em que X é 5 para homens e 4 para mulheres.[9]Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90.
http://www.ncbi.nlm.nih.gov/pubmed/29301420?tool=bestpractice.com
[43]Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-33.
https://www.doi.org/10.1002/hep.30866
http://www.ncbi.nlm.nih.gov/pubmed/31314133?tool=bestpractice.com
[44]Willenbring ML, Massey SH, Gardner MB. Helping patients who drink too much: an evidence-based guide for primary care clinicians. Am Fam Physician. 2009 Jul 1;80(1):44-50.
https://www.aafp.org/pubs/afp/issues/2009/0701/p44.html
http://www.ncbi.nlm.nih.gov/pubmed/19621845?tool=bestpractice.com
O teste é positivo se a resposta do paciente for >1, e uma ferramenta de avaliação formal, como o AUDIT, deve ser usada.[9]Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90.
http://www.ncbi.nlm.nih.gov/pubmed/29301420?tool=bestpractice.com
[43]Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-33.
https://www.doi.org/10.1002/hep.30866
http://www.ncbi.nlm.nih.gov/pubmed/31314133?tool=bestpractice.com
[44]Willenbring ML, Massey SH, Gardner MB. Helping patients who drink too much: an evidence-based guide for primary care clinicians. Am Fam Physician. 2009 Jul 1;80(1):44-50.
https://www.aafp.org/pubs/afp/issues/2009/0701/p44.html
http://www.ncbi.nlm.nih.gov/pubmed/19621845?tool=bestpractice.com
O rastreamento de consumo de álcool pode ser difícil em um ambiente clínico movimentado (por exemplo, o pronto-socorro) devido à limitação de recursos e/ou à falta de tempo. Testes com ferramentas de rastreamento simples, como CAGE e FAST (4 perguntas), podem ser realizados em cerca de 12 segundos. Já o AUDIT (10 perguntas) requer até 78 segundos para ser realizado.[81]Williams N. The FAST questionnaire. Occup Med (Lond). 2014 Oct;64(7):559-60.
https://academic.oup.com/occmed/article/64/7/559/1367378
http://www.ncbi.nlm.nih.gov/pubmed/25281578?tool=bestpractice.com
Portanto, é importante selecionar a ferramenta de rastreamento adequada para aplicação clínica.
Os pacientes com teste positivo para transtornos decorrentes do uso de bebidas alcoólicas e que apresentam risco de abstinência alcoólica devem ter seu grau de dependência alcoólica avaliado usando uma ferramenta de rastreamento formal, como o Severity of Alcohol Dependence Questionnaire ou o Leeds Dependence Questionnaire.[9]Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90.
http://www.ncbi.nlm.nih.gov/pubmed/29301420?tool=bestpractice.com
[45]Raistrick D, Bradshaw J, Tober G, et al. Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction. 1994 May;89(5):563-72.
http://www.ncbi.nlm.nih.gov/pubmed/8044122?tool=bestpractice.com
[46]Stockwell T, Hodgson R, Edwards G, et al. The development of a questionnaire to measure severity of alcohol dependence. Br J Addict Alcohol Other Drugs. 1979 Mar;74(1):79-87.
http://www.ncbi.nlm.nih.gov/pubmed/283831?tool=bestpractice.com
[47]Bråthen G, Ben-Menachem E, Brodtkorb E, et al. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol. 2005 Aug;12(8):575-81.
https://www.doi.org/10.1111/j.1468-1331.2005.01247.x
http://www.ncbi.nlm.nih.gov/pubmed/16053464?tool=bestpractice.com
[82]Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984 Oct 12;252(14):1905-7.
http://www.ncbi.nlm.nih.gov/pubmed/6471323?tool=bestpractice.com
AUDIT-C, FAST, CAGE e AUDIT apenas identificam transtornos decorrentes do uso de bebidas alcoólicas e não preveem quais pacientes apresentam risco de abstinência alcoólica.
Pacientes com rebaixamento do nível de consciência e que não podem ser rastreados pelos métodos acima devem ser monitorados para sinais clínicos de abstinência alcoólica.[5]American Society of Addiction Medicine. The ASAM clinical practice guideline on alcohol withdrawal management. J Addict Med. 2020 May/Jun;14(3s suppl 1):1-72.
https://www.doi.org/10.1097/ADM.0000000000000668
http://www.ncbi.nlm.nih.gov/pubmed/32511109?tool=bestpractice.com
Pacientes na unidade de terapia intensiva com suspeita de serem dependentes de bebidas alcoólicas devem receber tratamento profilático para abstinência alcoólica.[5]American Society of Addiction Medicine. The ASAM clinical practice guideline on alcohol withdrawal management. J Addict Med. 2020 May/Jun;14(3s suppl 1):1-72.
https://www.doi.org/10.1097/ADM.0000000000000668
http://www.ncbi.nlm.nih.gov/pubmed/32511109?tool=bestpractice.com